Optimum Investment Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q1 | – | Sell |
-14,425
| Closed | -$729K | – | 279 |
|
2015
Q4 | $729K | Sell |
14,425
-1,605
| -10% | -$81.1K | 0.28% | 109 |
|
2015
Q3 | $733K | Buy |
+16,030
| New | +$733K | 0.3% | 103 |
|
2015
Q1 | $843K | Buy |
15,295
+3,015
| +25% | +$166K | 0.27% | 104 |
|
2014
Q4 | $616K | Buy |
12,280
+4,035
| +49% | +$202K | 0.2% | 134 |
|
2014
Q3 | $381K | Buy |
8,245
+750
| +10% | +$34.7K | 0.13% | 168 |
|
2014
Q2 | $328K | Buy |
7,495
+630
| +9% | +$27.6K | 0.11% | 190 |
|
2014
Q1 | $286K | Buy |
6,865
+4,640
| +209% | +$193K | 0.11% | 190 |
|
2013
Q4 | $82K | Buy |
2,225
+900
| +68% | +$33.2K | 0.03% | 320 |
|
2013
Q3 | $46K | Buy |
+1,325
| New | +$46K | 0.02% | 382 |
|